WHO ICTRP trial
Feasibility of MRI guided focal high-dose-rate brachytherapy for localized…
NL-OMON21756 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON21756 |
|---|---|
| Public title | Feasibility of MRI guided focal high-dose-rate brachytherapy for localized prostate cancer (Plaatselijke inwendige bestraling voor patiënten met prostaatkanker). |
| Scientific title | Feasibility of MRI guided focal high-dose-rate brachytherapy for localized prostate cancer. |
| Primary sponsor | University Medical Center Utrecht |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | High-dose-rate brachytherapy MRI-guided Localized prostate cancer |
| Interventions | High-dose-rate brachytherapy will be performed for patients with low to intermediate risk prostate carcinoma. The treatment will include a single fraction of 19 Gy. High-dose-rate brachytherapy will be performed by insertion of catheters… |
| Registration date | Jan 11, 2013 |
| Target size | 30 |
| Secondary IDs | NL3624;NTR3790;METC UMCU : METC 12-402;ISRCTN wordt niet meer aangevraagd. |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: